Fette Compacting and Glatt Partner to Develop Continuous Manufacturing Solutions

Published on: 

Fette Compacting and Glatt have joined forces to develop integrated solutions for the continuous manufacturing of oral solid-dosage drug forms.

Fette Compacting, which produces tablet compression equipment, and Glatt, which specializes in powder processing and tablet coating, have joined forces to develop integrated solutions for the continuous manufacturing of oral solid dosage (OSD) forms, the companies announced in a Nov. 28, 2017 press release. The new offering combines the know-how and experience of Fette Compacting and Glatt in the areas of pharmaceutical process technology and equipment design to provide OSD drug manufacturers with continuous manufacturing solutions for formulation development, clinical trials, and pilot and commercial production.

“Our aim is to jointly develop a technology platform for continuous manufacturing of OSD that outperforms the competition in terms of process robustness, product quality and yield, efficiency, productivity, and operator safety,” said Fette Compacting CEO Olaf J. Müller in the press release.

At the P-MEC 2018 trade fair in Mumbai, India, the two companies exhibited the first continuous line resulting from the cooperation. In the future, the two companies will focus on the development of comprehensive integrated solutions for direct compression and granulation-based continuous manufacturing lines, including advanced process control systems. Beginning in February 2018, Glatt and Fette Compacting will offer customer trials for continuous direct compression and continuous wet granulation in Pune, India in a new test facility.

Advertisement

Source: Fette Compacting